Jerrold M. Olefsky

Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ.

Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA.

Cure DM, Inc. operates as a biopharmaceutical company. It develops new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin. The company was founded by Loraine V. Upham, Claresa S. Levetan and Rita El-Hajj in 2004 and is headquartered in Wilmington, DE.

Synedgen, Inc. operates as a biotechnology company leveraging a proprietary glycomics technology platform to develop modified therapeutic polysaccharides that target mucosal surfaces in genetic and acquired disorders. The firm’s products include Prisyna oral care and Synedgen wound care. The company was founded by William P. Wiesmann and Shenda Baker in 2009 and is headquartered in Claremont, CA.

Microdermis Corp. engages in the prevention and control of infectious diseases. Its dermatological delivery platform Amidermal® produces compelling products with significantly-enhanced performance, low manufacturing costs, and rapid time-to-market. Its product Provodine® is an antiseptic that can be use as a surgical scrub, pre-operative skin preparation, healthcare personnel hand wash, and first aid antiseptic. The company was founded in October 2010 and is headquartered in Princeton, NJ.

The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010.

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

San Diego Regional Economic Development Corp. operates as a non-profit organization. It mobilizes business, government, and civic leaders to maximize the region’s economic prosperity and global competitiveness. The company is headquartered in San Diego, CA.

Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life.

EKF-diagnostic GmbH engages in the development, manufacture, and distribution of medical equipment. It produces point of care analyzers for the measurement of glucose, lactate, hemoglobin, hematocrit, and glycated hemoglobin. Its products include Quo-Test, Quo-Lab, Biosen, CardioChek Plus, Lactate Scout+, Hemo Control, Crematocrit Plus, Hemo Vet, and DiaSpectTM. The company was founded by Berthold Walter in 1990 and is headquartered in Barleben, Germany.

CeQur SA develops medical devices for diabetes patients. It offers n insulin delivery device that provides three days of consistent, basal insulin deliver along with on-demand bolus insulin. The company was founded by James L. Peterson in January 2008 and is headquartered in Horw, Switzerland.

Biolinq, Inc. develops skin-applied electronic sensors that analyze body fluids to provide health information. The company was founded by Jared Tangney and Josh Windmiller in 2012 and is headquartered in San Diego, CA.

Biocon Biologics India Ltd. operates as a biotech company. It develops treatments for chronicle diseases. The company is headquartered in Bengaluru, India.

ADCY5 Org provides support services for adolescents.

Continuum Biosciences, Inc. operates as a biotech company that focuses on diseases such as obesity, diabetes, and ageing. The company was founded in 2017 and is headquartered in Blacksburg, VA.

Persephone Biosciences, Inc. engages in developing nutritional products to support the human gut microbiome. The company was founded by Stephanie Culler and is headquartered in Dan Diego, CA.

DelNova, Inc. engages in the development of therapeutics. Its lead clinical candidate is ReViVox?, a patent-pending product for the rescue of complications caused by off-target muscle paralysis following aesthetic and medical neurotoxin therapies. The company was founded by Mary Gardner in 2016 and is headquartered in Highland, IL.

Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA.

ProSciento, Inc. is a full-service clinical research organization that works with biopharma companies worldwide to support their outsourced clinical research needs. The company is based in Chula Vista, CA, and has subsidiaries in the United States. The company specializes in providing comprehensive and customized services for multinational, early development clinical trial programs for metabolic continuum diseases, including diabetes, obesity, and steatotic liver disease. ProSciento has conducted over 300 clinical projects and supported the development of many approved metabolic drugs and devices on the market. ProSciento was founded in 2003, and Marcus Hompesch has been the CEO of the company since its inception.

Abilita Therapeutics, Inc. is a biotechnology company that focuses on discovering and developing drugs that target challenging human membrane proteins with high medical impact, such as GPCRs, ion channels, and transporters. The company is based in San Diego, CA. The company's internal drug discovery pipeline is focused on treating cancer and chronic pain. Abilita Bios EMP™ platform fuels research collaborations with pharmaceutical and biotech partners. The company was founded in 2014 by Mauro Mileni, who has been the CEO since 2014.

Biocon Biologics UK Ltd. is a biopharmaceutical company founded in 2016. The private company is based in London, UK. The British company is focused on finding new and affordable ways to treat diabetes, cancer, and autoimmune diseases. Biocon develops affordable biosimilars, generic formulations, and complex APIs. The company's work in novel biologics and novel targets in large molecules has significant results in diabetes, oncology, and immunology. The company provides access to share information, news, press releases, company statements, media stories, factsheet, leadership profile, reports, video, and image gallery. Syngene, a division of Biocon, is divided into four divisions - drug discovery services, drug development services, manufacturing services, and dedicated R&D centers.